<DOC>
	<DOCNO>NCT02026518</DOCNO>
	<brief_summary>Fasting blood specimen take patient IBS inclusion criterion . First , objectives method study explain patient informed consent form take . They divide 4 group adjust randomized block clinical outcome , quality life , emotional stress questionnaire complete intervention . During 6 week , receive 2 capsule soy isoflavones per day , 50000IU vitamin D biweekly addition placebo form , placebo . At end , body mass index ( BMI ) , serum TNF-Alpha , TAC , gene expression GATA3 , ROR gamma , FOXP3 lymphocytes gut permeability measure . The quantity polymorphisms vitamin D estrogen receptor determine .</brief_summary>
	<brief_title>Effect Cholecalciferol , Soy Isoflavones Patients With Irritable Bowel Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>1. age 1875 yr 2. patient Irritable Bowel Syndrome ( IBS ) accord ROME III criteria 3 . BMI 1825 4. intestinal organic disease b intestinal infection c history chronic gastrointestinal colorectal diseases intestinal major surgery 5. regular use antibiotic , anticonstipation antidiarrhea , immune suppressor , metoclopramide , cisapride , diphenoxylate , opium nonsteroidal antiinflammatory drug 6. pregnancy lactation 7. athlete bed rest 8. history breast cancer family 9. severe psychosis 1. use soy isoflavones vitamin D one year study b use soy milk soy nut study 2. diet change study 3. use artificial sweetener 2 day study 4. desire complete study 5. adverse effect supplement 6. pregnancy study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>